Integrated In Vitro and In Silico Assessment of Dexamethasone‐Induced Cytotoxicity and Genotoxicity

Dexamethasone is a widely used glucocorticoid with potent anti-inflammatory and immunosuppressive properties. Despite its broad clinical application, its cellular toxicity responses under experimental exposure conditions remain incompletely characterized. This study evaluated the cellular responses associated with dexamethasone exposure using complementary in vitro and in silico approaches. Cytotoxicity was assessed in MCF-7, Caco-2, Vero, and HFB4 cell lines using the MTT assay. MCF-7 cells were subsequently selected for apoptosis and cell cycle analysis by flow cytometry based on their greater sensitivity to dexamethasone. DNA damage-associated responses were independently evaluated using the Saccharomyces cerevisiae yeast comet assay in three knockout strains. Complementary computational analyses included UALCAN gene expression profiling, STRING and GeneMANIA protein-protein interaction analyses, and molecular docking of dexamethasone with CASP3 and BCL-2. Dexamethasone produced concentration-dependent reductions in cell viability across the tested cell lines and was associated with increased apoptotic and necrotic populations and altered cell cycle distribution in MCF-7 cells. The yeast comet assay showed increased DNA damage-associated parameters following dexamethasone exposure, with responses varying among the tested knockout strains. Computational analyses provided contextual information regarding apoptosis-associated genes and protein networks, while molecular docking identified predicted structural compatibility between dexamethasone and CASP3/BCL-2. These computational findings are hypothesis generating and do not establish treatment-specific gene regulation, direct target engagement, or causal molecular mechanisms. Overall, dexamethasone elicited multiple cellular responses under the present experimental conditions, including reduced metabolic activity, apoptosis-associated changes, altered cell cycle distribution, and DNA damage-associated responses in an independent yeast model. Further studies using mammalian genotoxicity assays and direct molecular validation are required to establish the underlying mechanisms.

Authors

Institutions

Publication Details

Journal
Journal of Applied Toxicology
Published
2026-11-16
DOI
https://doi.org/10.1002/jat.70505
Primary Topic
Carcinogens and Genotoxicity Assessment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated In Vitro and In Silico Assessment of Dexamethasone‐Induced Cytotoxicity and Genotoxicity

A. Haggran, Shimaa E. Rashad
Journal of Applied Toxicology
Carcinogens and Genotoxicity Assessment
article

Integrated In Vitro and In Silico Assessment of Dexamethasone‐Induced Cytotoxicity and Genotoxicity

A. Haggran, Shimaa E. Rashad
article en

Abstract

Dexamethasone is a widely used glucocorticoid with potent anti-inflammatory and immunosuppressive properties. Despite its broad clinical application, its cellular toxicity responses under experimental exposure conditions remain incompletely characterized. This study evaluated the cellular responses associated with dexamethasone exposure using complementary in vitro and in silico approaches. Cytotoxicity was assessed in MCF-7, Caco-2, Vero, and HFB4 cell lines using the MTT assay. MCF-7 cells were subsequently selected for apoptosis and cell cycle analysis by flow cytometry based on their greater sensitivity to dexamethasone. DNA damage-associated responses were independently evaluated using the Saccharomyces cerevisiae yeast comet assay in three knockout strains. Complementary computational analyses included UALCAN gene expression profiling, STRING and GeneMANIA protein-protein interaction analyses, and molecular docking of dexamethasone with CASP3 and BCL-2. Dexamethasone produced concentration-dependent reductions in cell viability across the tested cell lines and was associated with increased apoptotic and necrotic populations and altered cell cycle distribution in MCF-7 cells. The yeast comet assay showed increased DNA damage-associated parameters following dexamethasone exposure, with responses varying among the tested knockout strains. Computational analyses provided contextual information regarding apoptosis-associated genes and protein networks, while molecular docking identified predicted structural compatibility between dexamethasone and CASP3/BCL-2. These computational findings are hypothesis generating and do not establish treatment-specific gene regulation, direct target engagement, or causal molecular mechanisms. Overall, dexamethasone elicited multiple cellular responses under the present experimental conditions, including reduced metabolic activity, apoptosis-associated changes, altered cell cycle distribution, and DNA damage-associated responses in an independent yeast model. Further studies using mammalian genotoxicity assays and direct molecular validation are required to establish the underlying mechanisms.

Journal of Applied Toxicology
National Research Centre (EG)
Carcinogens and Genotoxicity Assessment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon